Quarterly Result25 May 2026, 01:39 pm
Mahamaya Lifesciences: Audited Results for FY26
AI Summary
Mahamaya Lifesciences Ltd has announced its audited standalone and consolidated financial results along with the auditor's report for the half year and financial year ended March 31, 2026. The announcement was made pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following a Board of Directors meeting held on May 25, 2026. The results include the financials of its subsidiary, Mahamaya Lifesciences (FZE) based in UAE.
Key Highlights
- Audited standalone financial results approved for FY26.
- Audited consolidated financial results approved for FY26.
- Auditor's report included in the filing.
- Board meeting held on May 25, 2026, to approve results.
- Results comply with SEBI Listing Regulations.
Price Impact
More from MAHALIFE